Robeco Institutional Asset Management B.V. cut its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 29.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 109,321 shares of the company’s stock after selling 44,746 shares during […]